Back to Search
Start Over
Functional outcomes of extended-release methylphenidate and atomoxetine in children: retrospective chart analysis
- Source :
- The Egyptian Journal of Neurology, Psychiatry and Neurosurgery, Vol 58, Iss 1, Pp 1-16 (2022)
- Publication Year :
- 2022
- Publisher :
- SpringerOpen, 2022.
-
Abstract
- Abstract Background Recent guidelines emphasize the importance of functional outcomes in children with attention-deficit/hyperactivity disorder (ADHD). Here, we assess the functional outcomes of the oral delivery system of osmotic-release methylphenidate (OROS-MPH) and atomoxetine (ATX) from the retrospective review of the chart for the last 2 years in the clinic. Results Linear mixed-effects models were performed with outcome measures of difference in ADHD symptoms and functional impairment. After 9–12 weeks, OROS-MPH and ATX were statistically equivalent for total Weiss Functional Impairment Rating Scale-Parent Report (WFIRS-P) scores (difference in slope is β = 0.004, p = 1.000). However, OROS-MPH was superior to ATX in terms of school domain (difference in slope is β = 0.139, p
Details
- Language :
- English
- ISSN :
- 16878329
- Volume :
- 58
- Issue :
- 1
- Database :
- Directory of Open Access Journals
- Journal :
- The Egyptian Journal of Neurology, Psychiatry and Neurosurgery
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.5e06a3f0ced42ca8fbab3cdccf04ff5
- Document Type :
- article
- Full Text :
- https://doi.org/10.1186/s41983-022-00532-3